Loading…
Go to symposium website → www.slas.org/HighContentAnalysis
avatar for Anita Naidoo, MPhil, BSC

Anita Naidoo, MPhil, BSC

GlaxoSmithKline Research and Development
Scientific Leader
Anita joined GlaxoSmithKline as a Genetic Toxicologist in 1988 and then moved into Cellular Pathology & Toxicology and re-trained as an in vitro toxicologist, applying her knowledge and expertise to develop cellular models to address safety concerns through bespoke mechanistic studies. Anita also has a deeper interest in more complex 3D tissue models and has just completed an 18-month secondment within GSK, collaborating with the University Medical Centre, Utrecht, and the Immunology Network on a project investigating introducing immune cells into a multicellular 3D tissue model.